Cognition Therapeutics (CGTX) Other Accumulated Expenses (2020 - 2026)
Cognition Therapeutics (CGTX) reported Other Accumulated Expenses of $194000.0 for Q1 2026, up 20.5% year-over-year from $161000.0 in Q1 2025, and down 36.81% on a QoQ basis from $307000.0 in Q4 2025.
Cognition Therapeutics (CGTX) has 7 years of Other Accumulated Expenses data on file, last reported at $194000.0 in Q1 2026.
- Quarterly Other Accumulated Expenses rose 20.5% year-over-year to $194000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $194000.0 (up 20.5% YoY) and the FY2025 annual result came in at $307000.0, up 10.04% from the prior year.
- Other Accumulated Expenses eased to $194000.0 in Q1 2026 per CGTX's latest filing, from $307000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $634000.0 in Q4 2022 and bottomed at $2000.0 in Q1 2022.
- The 5-year median for Other Accumulated Expenses is $217000.0 (2023), against an average of $253000.0.
- The widest annual swing landed in 2022, when Other Accumulated Expenses tumbled 96.28%; it then soared 21250.0% in 2023.
- Tracing CGTX's Other Accumulated Expenses over 5 years: stood at $634000.0 in 2022, then dropped by 14.2% to $544000.0 in 2023, then sank by 48.71% to $279000.0 in 2024, then gained by 10.04% to $307000.0 in 2025, then sank by 36.81% to $194000.0 in 2026.
- Per Business Quant, the three latest CGTX Other Accumulated Expenses figures stand at $194000.0 (Q1 2026), $307000.0 (Q4 2025), and $41000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 194,000.00 |
| Dec 31, 2025 | 307,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 161,000.00 |
| Dec 31, 2024 | 279,000.00 |
| Jun 30, 2024 | 185,000.00 |
| Mar 31, 2024 | 366,000.00 |
| Dec 31, 2023 | 544,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 217,000.00 |
| Mar 31, 2023 | 427,000.00 |
| Dec 31, 2022 | 634,000.00 |
| Sep 30, 2022 | 34,000.00 |
| Jun 30, 2022 | 402,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 1.19 Mn |
| Sep 30, 2021 | 913,000.00 |
| Dec 31, 2020 | 253,000.00 |